Clinical trial
Dexmedetomidine for Continuous Sedation
NCT00226785 · Orion Corporation, Orion Pharma, Industry · Terminated
Key facts
| NCT number | NCT00226785 |
|---|---|
| Title | Dexmedetomidine for Continuous Sedation |
| Official title | A Prospective, Multi-Centre, Randomised, Double-Blind Comparison of Intravenous Dexmedetomidine With Propofol/Midazolam for Continuous Sedation (24 Hours to 14 Days) of Ventilated Patients in Intensive Care Unit |
| Lead sponsor | Orion Corporation, Orion Pharma, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Conscious Sedation |
| Intervention type | Drug |
| Interventions | Dexmedetomidine |
| Enrollment | 900 |
| Start date | Oct 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Sep 27, 2005 |
| Last update posted | Nov 14, 2006 |
| Countries | Finland, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: